Millennium Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
Other funds holding ATYR
KCM
Millennium Management's ATYR Position: Q2 2026 in Review
Millennium Management reduced its aTyr Pharma (ATYR) stake by 60% in Q2 2026, selling an estimated $644K and leaving 16,401 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #4947.
Millennium Management first reported a position in ATYR in Q4 2015 and has held it in 25 quarters since. The position peaked at $8.11M in Q2 2025. 87 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.
- Millennium Management held 16,401 shares of aTyr Pharma worth $392K as of Q2 2026.
- Millennium Management sold 24,630 aTyr Pharma shares in Q2 2026, an estimated $644K.
- aTyr Pharma made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #4947 holding.
- Millennium Management first reported a position in aTyr Pharma in Q4 2015 and has held it in 25 quarters since.
- Millennium Management's aTyr Pharma position peaked at $8.11M in Q2 2025.
- 87 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.